India · Delayed Price · Currency is INR Oncternal Therapeutics Statistics
Total Valuation
BOM:530433 has a market cap or net worth of INR 486.06 million. The enterprise value is 1.16 billion.
| Market Cap | 486.06M |
| Enterprise Value | 1.16B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:530433 has 9.99 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 9.99M |
| Shares Outstanding | 9.99M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 69.21% |
| Owned by Institutions (%) | 3.41% |
| Float | 2.67M |
Valuation Ratios
The trailing PE ratio is 5.22.
| PE Ratio | 5.22 |
| Forward PE | n/a |
| PS Ratio | 0.13 |
| PB Ratio | 0.44 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.47 |
| EV / Sales | 0.32 |
| EV / EBITDA | 12.69 |
| EV / EBIT | 16.74 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 5.21 |
| Debt / FCF | n/a |
| Interest Coverage | 1.06 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 2.21% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 32.91M |
| Profits Per Employee | 838,495 |
| Employee Count | 111 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:530433 has paid 35.24 million in taxes.
| Income Tax | 35.24M |
| Effective Tax Rate | 33.92% |
Stock Price Statistics
The stock price has increased by +13.01% in the last 52 weeks. The beta is -0.97, so BOM:530433's price volatility has been lower than the market average.
| Beta (5Y) | -0.97 |
| 52-Week Price Change | +13.01% |
| 50-Day Moving Average | 41.70 |
| 200-Day Moving Average | 41.71 |
| Relative Strength Index (RSI) | 63.03 |
| Average Volume (20 Days) | 18,292 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:530433 had revenue of INR 3.65 billion and earned 93.07 million in profits. Earnings per share was 9.31.
| Revenue | 3.65B |
| Gross Profit | 429.09M |
| Operating Income | 69.33M |
| Pretax Income | 103.91M |
| Net Income | 93.07M |
| EBITDA | 91.50M |
| EBIT | 69.33M |
| Earnings Per Share (EPS) | 9.31 |
Balance Sheet
The company has 5.48 million in cash and 477.05 million in debt, giving a net cash position of -471.57 million or -47.19 per share.
| Cash & Cash Equivalents | 5.48M |
| Total Debt | 477.05M |
| Net Cash | -471.57M |
| Net Cash Per Share | -47.19 |
| Equity (Book Value) | 1.09B |
| Book Value Per Share | 89.13 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 11.75%, with operating and profit margins of 1.90% and 2.55%.
| Gross Margin | 11.75% |
| Operating Margin | 1.90% |
| Pretax Margin | 2.84% |
| Profit Margin | 2.55% |
| EBITDA Margin | 2.50% |
| EBIT Margin | 1.90% |
| FCF Margin | n/a |
Dividends & Yields
BOM:530433 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | n/a |
| Earnings Yield | 19.15% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |